Trial Profile
A study to determine the curative effect and mechanism of Apatinib combined with chemotherapy for SD patients with advanced malignant solid tumor
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 17 Nov 2016 New trial record